COVID-19 Vaccine Transparency

Dance to My Rhythm | Health Research | Evidence & DiscernmentResearch snapshot: October 15, 2026 Status: Living source review; update when new primary evidence becomes available.

Why examine this?

People deserve clear answers about what medical products contain, how they were developed, what risks have been identified, and where evidence remains incomplete. That means taking concerns seriously without treating an allegation as an established fact. This overview separates documented findings, disputed interpretations, and claims that have not been substantiated.

Did an experimental COVID-19 vaccine use material derived from an HIV protein?

Yes. The University of Queensland and CSL developed an experimental COVID-19 vaccine candidate named UQ-CSL v451. Its molecular-clamp technology incorporated fragments of gp41, a protein associated with HIV, to stabilize the SARS-CoV-2 spike protein for vaccine development. In a 2020 Phase 1 trial, some participants produced antibodies that reacted with certain HIV screening tests, causing false-positive HIV screening results.

The University of Queensland and CSL reported that follow-up testing found no HIV infection in the participants. The candidate did not proceed to Phase 2/3 trials and was not rolled out as an approved COVID-19 vaccine. Its history is real; it does not demonstrate that the vaccines subsequently approved for use contain HIV or cause HIV infection.

Primary record: University of Queensland, December 11, 2020: Read source →

Corroborating reporting: Australian Broadcasting Corporation, December 11, 2020: Read source →

What ingredients are disclosed in approved Pfizer and Moderna vaccines?

The 2026–2027 FDA prescribing information for COMIRNATY (Pfizer/BioNTech) and SPIKEVAX (Moderna) lists modified mRNA, lipid components (including PEG-containing lipids and cholesterol), stabilizers such as sucrose, and buffering ingredients. The exact formulation and quantity depend on the product and dose. These formulation components are often termed excipients; calling them “fillers” is informal, not evidence of undisclosed toxic material.

HIV proteins or HIV genetic material are not listed as ingredients in these approved products. The source records reviewed for this article do not substantiate the assertion that the approved Pfizer or Moderna vaccines contain “traces of HIV.” Ingredient labels alone cannot resolve every possible laboratory-contamination allegation; such a claim would require reliable, reproducible testing tied to identified lots, methods and independently validated results.

Primary source: Pfizer/BioNTech COMIRNATY FDA package insert (revised August 2026):Read source →

Primary source: Moderna SPIKEVAX FDA package insert, 2026–2027 formula:Read source →

What about residual DNA and questions about SV40 sequences?

Residual manufacturing DNA is a separate issue from HIV. Making some mRNA vaccines involves a DNA template. The manufacturing process includes purification steps intended to break down and remove template DNA, but very small residual DNA fragments may remain. In its December 14, 2023 response to Florida's surgeon general, the FDA described production controls and stated that it had not identified safety concerns attributable to residual DNA.

Florida's surgeon general publicly challenged that assessment, expressing concerns about residual DNA and an SV40 promoter/enhancer sequence. A promoter/enhancer DNA sequence is not the same thing as an intact SV40 virus, an SV40 protein, or HIV. The dispute concerns how to interpret evidence of exposure and potential risk; it is not proof that the vaccines contain infectious SV40 or HIV, nor proof of genetic harm in recipients.

Primary source: FDA letter, December 14, 2023:Read source →

Primary source: Florida Department of Health statement, January 3, 2024:Read source →

Are there documented risks from mRNA COVID-19 vaccines?

Yes. The FDA has required warnings about myocarditis and pericarditis after mRNA COVID-19 vaccination. In its June 25, 2025 communication, the agency stated that observed risk was highest in males aged 12 to 24 years. This is a documented adverse-event concern and should be explained as part of informed consent. The presence of a recognized risk does not, by itself, establish any separate HIV-contamination claim.

Primary source: FDA safety communication, June 25, 2025:Read source →

Claims: documented, debated, or not established

  • A 2020 experimental COVID vaccine used fragments of an HIV-associated protein — Documented for the discontinued UQ-CSL v451 candidate.

  • Trial participants developed HIV infections from that candidate — Not supported; follow-up tests reported no HIV infection.

  • The Pfizer and Moderna vaccines have formulation ingredients beyond mRNA — Documented, in their package inserts.

  • Approved Pfizer or Moderna COVID vaccines contain HIV traces — Not substantiated by the reliable source records reviewed here.

  • Tiny residual DNA fragments can remain after mRNA production — Documented and subject to manufacturing controls.

  • Residual DNA necessarily causes genetic injury or cancer in vaccine recipients — Not established by the sources reviewed; risk interpretations have been disputed.

  • Myocarditis and pericarditis are recognized mRNA-vaccine risks — Documented in FDA safety warnings.

How readers can examine health-product claims critically

  1. Identify the exact product — manufacturer, formulation year, dose, and whether it was experimental or approved.

  2. Read the primary documents, including the current package insert and safety warnings, rather than relying only on headlines.

  3. Separate ingredients from manufacturing residues and distinguish fragments of a protein from an infectious virus.

  4. Ask what direct evidence supports an allegation — laboratory method, samples and lot numbers, controls, independent replication, and peer review.

  5. Discuss individual risks with an appropriately qualified clinician. Acknowledging documented vaccine risks and weighing them against the risks of infection is part of informed decision-making.

  6. Report suspected adverse events through official reporting channels and seek clinical assessment for concerning symptoms.

Editorial standard for Dance to My Rhythm

This article aims to promote independent inquiry, transparency and informed consent. It does not allege that every vaccine is harmful, that approved COVID-19 vaccines contain HIV, or that any unverified claim is settled fact. Conclusions will be corrected when credible new evidence warrants revision. Information here is educational, not individualized medical advice.

Continue exploring

Wellness & Food · Discernment · Research & Study